학술논문
Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: Results from the 5-year long-term extension of the phase III pivotal trials
Document Type
Article
Author
Ruperto, N.; Brunner, H.I.; Lovell, D.J.; Quartier, P.; Constantin, T.; Wulffraat, N.M.; Horneff, G.; Kasapcopur, O.; Schneider, R.; Anton, J.; Barash, J.; Berner, R.; Corona, F.; Cuttica, R.; Fouillet-Desjonqueres, M.; Fischbach, M.; Foster, H.E.; Foell, D.; Radominski, S.C.; Ramanan, A.V.; Trauzeddel, R.; Unsal, E.; Levy, J.; Vritzali, E.; Martini, A.
Source
In: Annals of the Rheumatic Diseases . (Annals of the Rheumatic Diseases, 1 December 2018, 77(12):1710-1719)
Subject
Language
English
ISSN
14682060
00034967
00034967